Neuroblastoma, a cancer mainly affecting children, is often difficult to treat. Researchers at Charité – Universitätsmedizin Berlin and the Max Delbrück Center now report a potential reason treatment sometimes fails. In the journal Cancer Discovery,*…
An interdisciplinary team of scientists from the Berlin Institute of Health at Charité (BIH), the Max Delbrück Center, the German Cancer Research Center (DKFZ), the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) and…
Beyond the hype: We are looking for AI and quantum technologies with real added value
Apply by 17 August 2025!
The EU-Japan Centre is targeting cutting-edge technologies sectors for its very first Innovation mission to Japan.
Deadline: 24.08.2025
Digital assistance system relieves nursing staff by providing real-time notifications of incontinence and movement, among other things
Eckert & Ziegler (ISIN DE0005659700) has entered a Master Service Agreement with Archeus Technologies (Archeus), a company developing multiple differentiated radiopharmaceutical therapies, for contract manufacturing of its novel investigational…
Hospitals generate vast amounts of data every day, which have the potential to significantly improve patient care. dotbase medical GmbH, a spin-off of the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin, has…
Application Deadline: October 15th, 2025
Partnership Brings Centauri™ PFA System to 17 European Markets, Enhancing Treatment Options for Atrial Fibrillation
